Apex Laboratory / Understanding the compound
Pinealon is a synthetic peptide made of three amino acids: glutamic acid, aspartic acid and arginine. Its sequence is abbreviated EDR. Researchers study it in connection with cellular stress, neuronal aging and behavior in animal models. That research explains the interest in Pinealon, but it does not establish that a research vial improves memory, treats a neurological condition or slows aging in people.
The useful question is not simply whether a paper mentions Pinealon. It is what was tested: isolated cells, an animal model, or people receiving a particular preparation. This guide separates those settings, explains the older human reports, and helps you compare Pinealon with related research materials.
The identity in three letters
Pinealon = E · D · R
- EGlu
Glutamic acid - DAsp
Aspartic acid - RArg
Arginine
What is Pinealon studied for?
The main interest is how EDR affects cells under stress and whether those effects matter in models of brain aging or injury. Terms such as neuroprotection describe what researchers are investigating. They should not be read as a demonstrated benefit for a person buying Pinealon.
01 / Cells
A response in a dish
Researchers can measure oxidative damage, cell survival or the branching of cultured neurons. Even cells originating from human donors are still a laboratory model.
02 / Animals
A defined experimental model
Animal behavior and tissue measurements can test a biological hypothesis. The species, induced condition and experimental setting limit what the result means.
03 / People
A different evidence question
Human reports require scrutiny of the preparation, comparison group, allocation, outcome measures and follow-up. A positive report does not automatically isolate the effect of EDR.
2011 / Cell experiments
Oxidative stress and cell survival
Khavinson and colleagues examined Pinealon in cerebellar granule cells, neutrophils and a cell line called PC12. They reported reduced accumulation of reactive oxygen species and reduced necrotic cell death under the tested stress conditions. Changes also involved the timing of ERK1/2 activation and the cell cycle. Read the primary study.
These are cellular measurements. They do not establish a safe human exposure, improved memory or protection from a neurological disease.
2012 / Rat-offspring model
Learning behavior in a specific stress model
Arutjunyan and colleagues studied offspring of rats exposed to experimental prenatal hyperhomocysteinemia. They reported improved spatial orientation and learning measures, together with greater resistance to oxidative stress in isolated cerebellar neurons, in the Pinealon experiment. Read the rat study.
This model is very different from normal human aging, everyday forgetfulness or a clinical memory disorder. Its result cannot answer whether Pinealon improves cognition in those situations.
2024 / Human-derived cells
More branching did not mean every cell measure improved
A newer study converted fibroblasts from older human donors into induced cortical neurons. EDR was among the peptides associated with greater dendritic branching, and it reduced oxidative DNA damage. The tripeptides did not improve the measured mitochondrial or lysosomal activity or the level of the p16 protein. Read the induced-neuron study.
The human origin of these cells does not make the experiment a trial in people. The mixture of positive and unchanged measurements also argues against a blanket claim that Pinealon “reverses cellular aging.”
Are there human studies of Pinealon?
There are older human reports involving Pinealon, but their presence does not establish reliable clinical effectiveness. A useful explanation should acknowledge those records and examine their limits, rather than simply saying “no human studies.”
Two reports worth reading carefully
A 2015 report by Meshchaninov and colleagues discusses Pinealon and Vesugen in a small population with multiple chronic conditions and organic brain syndrome in remission. Its abstract reports changes in biological-age indicators, but does not provide the design detail needed to establish a randomized, blinded test of Pinealon alone. It also describes prooxidant findings, which do not support a simple claim that every observed effect was antioxidant.
A 2012 occupational-health report begins with comparisons between truck drivers and metal craftsmen and describes peptide interventions, including combinations. The large occupational comparison sample must not be presented as a randomized trial showing that Pinealon alone improved memory. The study setting, combined preparations and reported psychoemotional measures all matter.
At our September 8, 2026 check, the specified ClinicalTrials.gov search for Pinealon, Glu-Asp-Arg and “EDR peptide” returned no records. That is a limited registry observation, not proof that no research has ever occurred. Published reports and registered trials are different kinds of records. Check the current registry.
How might Pinealon work?
The research proposes effects on cellular stress responses and gene regulation. The 2011 experiments measured changes in reactive oxygen species and signaling behavior. Later literature discusses possible interactions of short peptides with DNA or chromatin as one explanation for changes in gene expression.
These ideas remain hypotheses to test across relevant biological systems. Finding that a peptide can interact with a molecule in a laboratory or computer model does not demonstrate that a particular preparation reaches the human brain, engages that target or produces a clinical benefit. The 2020 EDR review provides a map of the proposed mechanisms; it is a secondary synthesis, not an additional clinical trial.
Is Pinealon the same as Epitalon?
No. Pinealon and Epitalon are different peptide sequences. Epitalon is also commonly spelled Epithalon. Their appearance together in discussions of short-peptide research does not make them interchangeable.
| Question | Pinealon | Epitalon / Epithalon |
|---|---|---|
| Sequence | Glu-Asp-Arg (EDR) | Ala-Glu-Asp-Gly (AEDG) |
| Length | Three amino acids | Four amino acids |
What the difference establishes: Different chemical identities, requiring their own material records and evidence appraisal.
What it does not establish: Which is clinically more effective, whether combining them helps, or whether either is appropriate for a person.
The 2017 AEDG identity paper and 2024 comparison of short peptides in induced neurons help distinguish the sequences. For the separate telomere and aging literature, continue to the Epithalon research guide.
What about sleep, memory and side effects?
Does Pinealon improve sleep?
The name is often encountered alongside pineal-gland and aging research. That association does not establish a sleep benefit. The studies reviewed here do not establish Pinealon as a treatment for insomnia or demonstrate a reliable improvement in sleep quality in people.
Does it improve memory?
The rat learning experiments and older human reports explain why this question comes up. They do not establish an effective memory treatment for healthy adults or people with a diagnosed condition. A behavioral task in a particular rat model cannot be converted into a human benefit percentage.
What side effects are known?
The available studies do not provide a dependable rate of human adverse effects for Apex’s research material. A favorable cell-survival result is not a comprehensive safety assessment, and an absence of detailed adverse-event reporting is not proof of safety. Experimental findings should not be used to construct a personal dose, timing schedule or combination protocol.
From the literature to a specific material
What should you check when comparing Pinealon?
Start with identity and documentation. A common name, a sequence and a laboratory report answer different parts of the material-selection question.
- Identity: confirm that the material is the EDR tripeptide described in your research plan.
- Configuration: match the product and stated vial amount to the correct record.
- Report scope: read the named lot, issue date, method and reporting basis. A published record is not a guarantee that the same lot is currently shipping.
- Research purpose: distinguish a chemical reagent from a formulated product tested in a clinical report.
Apex’s published Pinealon 10 mg record for lot APX-2026-0412-P is a specific document to inspect, not a substitute for clinical evidence. Current price and availability belong on the product page.
View Pinealon research material
For the broader distinction, read research-grade versus pharmaceutical-grade materials.
Frequently Asked Questions about Pinealon
What is Pinealon peptide?
Pinealon is the synthetic tripeptide Glu-Asp-Arg, abbreviated EDR. Its three amino acids are glutamic acid, aspartic acid and arginine. It is studied in cellular-stress, neuronal-aging and animal-behavior models; those research interests do not establish a human treatment benefit.
Is Pinealon the same as EDR?
EDR is the one-letter amino-acid sequence used for the Pinealon peptide: glutamic acid, aspartic acid and arginine, in that order. When comparing materials, check the actual sequence and accompanying documentation rather than relying only on a product name.
What are the benefits of Pinealon?
The cited experiments report changes in cellular stress responses, neuronal branching and behavior in particular animal models. They do not establish a reliable therapeutic benefit in humans. The older human reports have substantial design and material-comparison limitations.
Are there human studies of Pinealon?
Older reports involving Pinealon and other peptide preparations do exist. Their design and reporting do not establish dependable clinical effectiveness for Pinealon alone. Experiments on cells from human donors are separate laboratory studies, not trials in human participants.
Is Pinealon the same as Epitalon?
No. Pinealon is the three-residue EDR peptide. Epitalon, also spelled Epithalon, is the four-residue AEDG peptide. Different sequences require separate identity records and evidence appraisal; the names do not establish comparable effects or a useful combination.
Does Pinealon help with sleep?
The studies reviewed here do not establish Pinealon as a treatment for insomnia or demonstrate a reliable human sleep benefit. An association with pineal-gland research is not enough to establish an effect on sleep quality.
Where can I find Apex Pinealon price and product details?
The Apex Laboratory Pinealon product page lists the current research-material configuration, price, availability and published record links. A learning article or an older report should not be treated as current inventory or proof of the lot being shipped.
References
- Khavinson et al. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Research. 2011. PMID 21978084.
- Arutjunyan et al. Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. International Journal of Clinical and Experimental Medicine. 2012. PMID 22567179.
- Kraskovskaya et al. Short Peptides Protect Fibroblast-Derived Induced Neurons from Age-Related Changes. International Journal of Molecular Sciences. 2024. PMID 39518916.
- Meshchaninov et al. Effect of synthetic peptides on aging of patients with chronic polymorbidity and organic brain syndrome of the central nervous system in remission. Advances in Gerontology. 2015. PMID 26390612.
- Bashkireva et al. The peptide correction of neurotic disorders among professional truck-drivers. Advances in Gerontology. 2012. PMID 23734521.
- Khavinson et al. EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer’s Disease. Molecules. 2020. Review. PMID 33396470.
- Khavinson et al. Identification of Peptide AEDG in the Polypeptide Complex of the Pineal Gland. Bulletin of Experimental Biology and Medicine. 2017. PMID 29124531.
